Loading...
Unité U1290 RESHAPE
(RESearch on HealthcAre PErformance)
Cette collection réunit les dépôts de l'ancien laboratoire HESPER et de l'actuel laboratoire RESHAPE.
Derniers dépôts
-
Aïm-Eusébi Amélie, Yannick Ruelle, Bernard Frèche, Mélanie Houllemare, Aurélie Bonillo, et al.. What do women and healthcare professionals expect of decision aids for breast cancer screening? A qualitative study in France. BMJ Open, 2022, 12 (3), pp.e058879. ⟨10.1136/bmjopen-2021-058879⟩. ⟨hal-03932008⟩
-
Tess Martin, Alessandra Guercio, Hélène Besseau, Laure Huot, Pascale Guerre, et al.. Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France. International Journal of Technology Assessment in Health Care, 2023, 39 (1), ⟨10.1017/S0266462323000521⟩. ⟨hal-04229548⟩
-
Gaël Roth, Yohan Fayet, Sakina Benmameche-Medjahed, Françoise Ducimetière, Amandine Charreton, et al.. Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort. Cancers, 2022, 14 (21), pp.5413. ⟨10.3390/cancers14215413⟩. ⟨hal-04490226⟩
-
Christelle de la Fouchardière, Mustapha Adham, Anne-Marie Marion-Audibert, Antoine Duclos, Claude Darcha, et al.. Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database. Cancers, 2021, 13 (14), pp.3515. ⟨10.3390/cancers13143515⟩. ⟨hal-04492495⟩
-
Gilles Kayem, Aurélien Seco, Françoise Vendittelli, Catherine Crenn Hebert, Corinne Dupont, et al.. Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study. Scientific Reports, 2024, 14 (1), pp.6564. ⟨10.1038/s41598-024-56964-9⟩. ⟨hal-04520022⟩